Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!
Allergan plc (NYSE:AGN) stock was trading higher by more than 2 percent early Monday morning after the company reported its first-quarter results. The pharmaceutical company said it earned $3.74 per share in the first quarter on revenue of $3.67 billion versus expectations of $3.35 per share and $3.59 billion.
First Data Corp (NYSE:FDC) soared higher by nearly 10 percent in reaction to its first-quarter results. The commerce-enabling technology and solutions company said it earned 29 cents per share in the first quarter on revenue of $2.08 billion versus expectations of 26 cents per share and $1.86 billion.
Sprint Corp (NYSE:S) fell nearly 15 percent despite confirming a merger agreement with T-Mobile Us Inc (NASDAQ:TMUS). The merger in the wireless telecom industry will see the No. 3 and No. 4 players combine into one entity. But the regulatory path ahead remains uncertain and requires the seal of approval from multiple regulatory agencies.
Pluristem Therapeutics Inc. (NASDAQ:PSTI) soared 16 percent. The developer of placenta-based cell therapy products said the FDA cleared its Investigational New Drug (IND) application for its PLX-R18 cell therapy in the treatment of acute radiation syndrome (ARS).
Edge Therapeutics Inc (NASDAQ:EDGE) inched higher by nearly 1 percent before shares were halted. The clinical-stage biotechnology said in a press release it's conducting a "comprehensive review of strategic alternatives focused on maximizing stockholder value."
26 Stocks Moving In Monday's Pre-Market Session
A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
